Is Bridging to Transplantation With a Left Ventricular Assist Device a Risk Factor for Transplant Coronary Artery Disease?

This publication has 16 references indexed in Scilit:

• Neoral use in the cardiac transplant recipient
  Transplantation Proceedings, 2000
• Intravenous Immunoglobulin Reduces Anti-HLA Alloreactivity and Shortens Waiting Time to Cardiac Transplantation in Highly Sensitized Left Ventricular Assist Device Recipients
  Circulation, 1999
• Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization
  The Journal of Heart and Lung Transplantation, 1999
• Preformed IgG Antibodies Against Major Histocompatibility Complex Class II Antigens Are Major Risk Factors for High-grade Cellular Rejection in Recipients of Heart Transplantation
  Circulation, 1998
• Factors Influencing HLA Sensitization in Implantable LVAD Recipients
  The Annals of Thoracic Surgery, 1997
• Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Retransplantation for severe accelerated coronary artery disease in heart transplant recipients
  The American Journal of Cardiology, 1988
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
  Circulation, 1987
• HEART GRAFT ARTERIOSCLEROSIS
  Transplantation, 1985
• Microdroplet Testing for HLA-A, -B, -C, and -D Antigens: The Philip Levine Award Lecture
  American Journal of Clinical Pathology, 1978